Shanghai Haoyuan Chemexpress Co., Ltd. researches, develops, and manufactures pharmaceutical intermediates and small molecule drugs. It offers APIs and API intermediates, vitamin D series compounds, CRO building blocks, and CRO life bioscience compounds. The company was founded in 2006 and is headquartered in Shanghai, China.
Stock data | 2024 | Change |
---|---|---|
Price | $3.50 | N/A |
Market Cap | $525.67M | N/A |
Shares Outstanding | 150.39M | N/A |
Employees | 3.37K | N/A |